| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/28/2010 | EP2209771A1 Cyclobutyl carboxylic acid derivatives |
| 07/28/2010 | EP2209769A1 Novel crystalline salts of montelukast |
| 07/28/2010 | EP2209768A1 5,6-diaryl pyridines substituted in the 2- and 3-position, preparation thereof and therapeutic use thereof |
| 07/28/2010 | EP2209761A1 Diphenyl substituted cycloalkanes |
| 07/28/2010 | EP2209529A2 Isoxazole compound for the treatment of cancer |
| 07/28/2010 | EP2209501A2 Zibotentan composition containing mannitol and/or microcrystalline cellulose |
| 07/28/2010 | EP2209498A2 Treatment of proliferative disorders using antibodies to psma |
| 07/28/2010 | EP2209493A2 Compositions comprising sphingosine 1 phosphate (s1p) receptor modulators |
| 07/28/2010 | EP2209478A1 Condensation products based on bicyclic or polycyclic aromatic or heteroaromatic compounds |
| 07/28/2010 | EP2209476A1 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders |
| 07/28/2010 | EP2209474A1 Broad spectrum beta-lactamase inhibitors |
| 07/28/2010 | EP2209473A1 Method of treating polycystic kidney diseases with ceramide derivatives |
| 07/28/2010 | EP2209471A2 Lipoxin a4 protection for cornea endothelial cells |
| 07/28/2010 | EP2209470A1 Pharmaceutical composition comprising peroxided oil and cholesterol and uses thereof in medical field |
| 07/28/2010 | EP2209469A2 Beta adrenergic receptor agonists for treatment of pain and/or inflammation |
| 07/28/2010 | EP2209468A1 Sustained-release chitosan capsules comprising chitosan and phytic acid |
| 07/28/2010 | EP2209466A2 Methods and compositions for treating post-operative pain comprising clonidine |
| 07/28/2010 | EP2209464A1 Anti-malarial pharmaceutical composition |
| 07/28/2010 | EP2209460A2 Cosmetic composition comprising hydroxymethionine and 3-aminopropanesulfonic acid |
| 07/28/2010 | EP2209450A1 Slow release of organic salts of local anesthetics for pain relief |
| 07/28/2010 | EP2209380A1 Method to use compositions having antidepressant anxiolytic and other neurological activity and compositions of matter |
| 07/28/2010 | EP2209379A2 Production of monatin enantiomers |
| 07/28/2010 | EP2209377A1 Use of vitamin d receptor agonists and precursors to treat fibrosis |
| 07/28/2010 | EP2209376A1 Novel seh inhibitors and their use |
| 07/28/2010 | EP2209375A1 Parp inhibitor compounds, compositions and methods of use |
| 07/28/2010 | EP2209374A1 Tubulysins and processes for preparing |
| 07/28/2010 | EP2209373A1 N-substituted oxindoline derivatives as calcium channel blockers |
| 07/28/2010 | EP2209371A1 Compositions and methods for treatment of diabetic retinopathy |
| 07/28/2010 | EP2086939B1 Pyridine carboxamides as 11-beta-hsd1 inhibitors |
| 07/28/2010 | EP2076494B1 Piperidine or piperazine substituted tetrahydro-naphthalene-1-carboxylic acid mtp inhibiting compounds |
| 07/28/2010 | EP2054048B1 Novel salts of the active substance rasagiline |
| 07/28/2010 | EP2016080B1 Dihydropyrazolopyrimidinone derivatives |
| 07/28/2010 | EP1963271B1 Quinolone m1 receptor positive allosteric modulators |
| 07/28/2010 | EP1963249B1 Biphenyl derivatives as selective agonists of gamma rar receptors |
| 07/28/2010 | EP1954677B1 Thiomorpholine compound and process for preparing the same |
| 07/28/2010 | EP1945182B1 Formulations of tipifarnib for intravenous application |
| 07/28/2010 | EP1874313B1 Treatment or prevention of ovarian hyperstimulation syndrome (ohss) using a dopamine agonist |
| 07/28/2010 | EP1838314B1 Process for preparing lansoprazole |
| 07/28/2010 | EP1827406B1 Anti-radical agents |
| 07/28/2010 | EP1814848B1 2,3,4-substituted-cyclopentanones as therapeutic agents |
| 07/28/2010 | EP1763511B1 Phenoxyacetic acid derivatives as ppar agonists |
| 07/28/2010 | EP1633746B1 New indole derivatives as factor xa inhibitors |
| 07/28/2010 | EP1574218B1 A medicament containing epimedium extract for treatment of prostatic hyperplasia and prostatitis |
| 07/28/2010 | EP1551844B1 Antitumoral analogs of lamellarins |
| 07/28/2010 | EP1545560B1 Compositions for inhibiting protein kinase c alpha for the treatment of diabetes mellitus |
| 07/28/2010 | EP1458392B9 Acridones as inhibitors of impdh enzyme |
| 07/28/2010 | EP1432403B1 Liposome loading with metal ions |
| 07/28/2010 | EP1397486B1 Polymorphisms in the human gene for cytochrome p450 polypeptide 2c8 and their use in diagnostic and therapeutic applications |
| 07/28/2010 | EP1369418B1 Quinazoline derivatives |
| 07/28/2010 | EP1315831B1 Stearoyl-coa desaturase to identify triglyceride reducing therapeutic agents |
| 07/28/2010 | EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 07/28/2010 | CN1984887B Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 07/28/2010 | CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors |
| 07/28/2010 | CN1972679B Pharmaceutical compositions comprising NEP-inhibitors, inhibitors of the endogenous endothelin producing system and AT1-receptor antagonists |
| 07/28/2010 | CN1929845B Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure |
| 07/28/2010 | CN1923198B Use of kurarinone in preparation of medicine for postoperative intestine functional restoration |
| 07/28/2010 | CN1905875B The use of quaternary pyridinium salts as vasoprotective agents |
| 07/28/2010 | CN1883492B Water solution of 20(R)-ginsenoside Rg3 pharmaceutical composition and preparation method thereof |
| 07/28/2010 | CN1872081B Application of kudzuvine root flavone in preparing medicine for treating chronic insufficiency of blood supply for brain |
| 07/28/2010 | CN1871021B Treating or preventing restless legs syndrome using prodrugs of GABA analogs |
| 07/28/2010 | CN1845907B Guanidine derivatives |
| 07/28/2010 | CN1794988B Composition for treating vascular hyperpermeable disease |
| 07/28/2010 | CN1788000B Phthalazinone derivatives |
| 07/28/2010 | CN1767819B Solid pharmaceutical compositions comprising a S1P receptor agonist and a sugar alcohol |
| 07/28/2010 | CN1762354B Stable pharmaceutical composition containing calcium blocker |
| 07/28/2010 | CN1548434B Benzothiophene compounds and their preparation and medicine use |
| 07/28/2010 | CN101790553A Alkylene oxide derivative and skin external preparation containing the same |
| 07/28/2010 | CN101790539A Amelioration of cellular stress response |
| 07/28/2010 | CN101790533A cyclopropyl fused indolobenzazepine hcv inhibitors |
| 07/28/2010 | CN101790531A Process for the preparation of pyrido [2, 1-a] isoquinoline derivatives and polymorphic froms thereof |
| 07/28/2010 | CN101790529A 8-azabicyclo[3.2.1]octyl-2-hydroxybenzamide compounds as mu opioid receptor antagonists |
| 07/28/2010 | CN101790528A aminoacyl prodrugs |
| 07/28/2010 | CN101790527A benzothiophene inhibitors of rho kinase |
| 07/28/2010 | CN101790525A pharmaceutical compounds |
| 07/28/2010 | CN101790524A 抗病毒化合物 Antiviral compounds |
| 07/28/2010 | CN101790522A Substituted piperazinyl pyrazines and pyridines as 5-ht7 receptor antagonists |
| 07/28/2010 | CN101790521A Substituted piperazines as cb1 antagonists |
| 07/28/2010 | CN101790519A 6-amino-pyrimidine-4-carboxamide derivatives and related compounds which bind to the sphingosine 1-phosphate (s1p) receptor for the treatment of multiple sclerosis |
| 07/28/2010 | CN101790518A Derivatives of 1-oxo-1,2-dihydroisoquinoline-5-carboxamides and of 4-oxo-3,4-dihydroquinazoline-8-carboxamides, preparation thereof and application thereof in therapeutics |
| 07/28/2010 | CN101790517A Inhibitor of binding of s1p1 |
| 07/28/2010 | CN101790516A Novel substituted piperidones as hsp inducers |
| 07/28/2010 | CN101790515A trans-3-aza-bicyclo[3.1.0]hexane derivatives |
| 07/28/2010 | CN101790514A 1-oxo-isoindoline-4-carboxamide and 1-oxo-1,2,3,4-tetrahydroisoquinoline-5-carboxamide derivatives, preparation and therapeutic use thereof |
| 07/28/2010 | CN101790513A 1,3-dihydroisoindole derivatives |
| 07/28/2010 | CN101790512A 2 -substituted- 3 -phenylpropionic acid derivatives and their use in the treatment of inflammatory bowel |
| 07/28/2010 | CN101790380A Conjugates of synthetic tlr agonists and uses therefor |
| 07/28/2010 | CN101790376A Tsh receptor antagonizing tetrahydroquinoline compounds |
| 07/28/2010 | CN101790374A Use of kncq potassium channel openers for reducing symptoms of or treating disorders or conditions wherein the dopaminergic system is disrupted |
| 07/28/2010 | CN101790373A Transdermal tobacco alkaloid reservoir patch |
| 07/28/2010 | CN101790371A Combination formulations comprising darunavir and etravirine |
| 07/28/2010 | CN101790370A A novel non-aqueous topical solution of diclofenac and process for preparing the same |
| 07/28/2010 | CN101790313A chemical compounds |
| 07/28/2010 | CN101790311A Benzylbenzene derivatives and methods of use |
| 07/28/2010 | CN101790310A Oncolytic vaccinia virus cancer therapy |
| 07/28/2010 | CN101790308A Method and apparatus for steam hydro-gasification with increased conversion times |
| 07/28/2010 | CN101787379A Preparation of microbial oil containing polyunsaturated fatty acids |
| 07/28/2010 | CN101787116A Compound and application thereof in preparing drug for curing viral respiratory infection |
| 07/28/2010 | CN101787072A Specific binding agents of human angiopoietin-2 |
| 07/28/2010 | CN101787070A Diosgenin deletion F-loop amino-acid ester derivatives and preparation method thereof |
| 07/28/2010 | CN101787068A Steroid saponin extract of Smilax riparia A.DC. and preparation method and application thereof |